ProtoDNA
源生康泰
ProtoDNA
Biotech/Healthcare
Beijing Yuansheng Kangtai Gene Technology Co., Ltd. applies advanced technologies including nanopore sequencing, IoT, 5G transmission, and big data cloud platforms to biomedicine.
Latest round: Series A (2021)
Source: ChinaBulls — chinabulls.com
Last updated 2021-02-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.